JP2003508517A5 - - Google Patents

Download PDF

Info

Publication number
JP2003508517A5
JP2003508517A5 JP2001521708A JP2001521708A JP2003508517A5 JP 2003508517 A5 JP2003508517 A5 JP 2003508517A5 JP 2001521708 A JP2001521708 A JP 2001521708A JP 2001521708 A JP2001521708 A JP 2001521708A JP 2003508517 A5 JP2003508517 A5 JP 2003508517A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001521708A
Other versions
JP4208463B2 (ja
JP2003508517A (ja
Filing date
Publication date
Priority claimed from GBGB9920919.9A external-priority patent/GB9920919D0/en
Application filed filed Critical
Publication of JP2003508517A publication Critical patent/JP2003508517A/ja
Publication of JP2003508517A5 publication Critical patent/JP2003508517A5/ja
Application granted granted Critical
Publication of JP4208463B2 publication Critical patent/JP4208463B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001521708A 1999-09-03 2000-09-01 キノロンカルボン酸誘導体の製造に関する中間体 Expired - Fee Related JP4208463B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9920919.9A GB9920919D0 (en) 1999-09-03 1999-09-03 Novel compound
GB9920919.9 1999-09-03
PCT/GB2000/003358 WO2001017961A2 (en) 1999-09-03 2000-09-01 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives

Publications (3)

Publication Number Publication Date
JP2003508517A JP2003508517A (ja) 2003-03-04
JP2003508517A5 true JP2003508517A5 (ja) 2005-12-22
JP4208463B2 JP4208463B2 (ja) 2009-01-14

Family

ID=10860355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001521708A Expired - Fee Related JP4208463B2 (ja) 1999-09-03 2000-09-01 キノロンカルボン酸誘導体の製造に関する中間体

Country Status (30)

Country Link
US (3) US6703512B1 (ja)
EP (1) EP1212321B1 (ja)
JP (1) JP4208463B2 (ja)
KR (1) KR100705363B1 (ja)
CN (1) CN1255402C (ja)
AR (1) AR029452A1 (ja)
AT (1) ATE270671T1 (ja)
AU (1) AU773698B2 (ja)
BR (1) BRPI0013750B8 (ja)
CA (1) CA2383751C (ja)
CO (1) CO5180620A1 (ja)
CZ (1) CZ2002759A3 (ja)
DE (1) DE60012028T2 (ja)
DK (1) DK1212321T3 (ja)
ES (1) ES2223570T3 (ja)
GB (1) GB9920919D0 (ja)
HK (1) HK1046908B (ja)
HU (1) HU229391B1 (ja)
IL (2) IL148441A0 (ja)
MX (1) MXPA02002356A (ja)
MY (1) MY126789A (ja)
NO (1) NO322501B1 (ja)
NZ (1) NZ517601A (ja)
PL (1) PL206491B1 (ja)
PT (1) PT1212321E (ja)
SI (1) SI1212321T1 (ja)
TR (1) TR200200548T2 (ja)
TW (1) TWI264435B (ja)
WO (1) WO2001017961A2 (ja)
ZA (1) ZA200201779B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
ES2314082T3 (es) 2001-08-02 2009-03-16 Lg Life Sciences Limited Procedimientos para la produccion de derivados amino protegidos de 4-aminometilenpirrolidin-3-ona, gemifloxacina y sus sales.
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
EP1521809B1 (en) * 2002-07-17 2005-11-23 Ciba SC Holding AG Oxidation process for preparing quinacridone pigments
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
US8822934B2 (en) * 2006-11-03 2014-09-02 Accuray Incorporated Collimator changer
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (ja) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のｐ‐トルエンスルホン酸塩
RU2049777C1 (ru) 1989-08-16 1995-12-10 Пфайзер Инк. Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
JPH0673056A (ja) 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
US5776944A (en) 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
EP0688772B1 (en) 1994-06-16 1999-05-06 LG Chemical Limited Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
UA59341C2 (uk) 1995-08-11 2003-09-15 Пфайзер, Інк. (1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат
DK0889880T3 (da) 1996-03-29 2003-09-01 Smithkline Beecham Corp Eprosartan-dihydrat og fremgangsmåde til fremstilling deraf samt formulering
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
AU4211799A (en) 1998-05-29 1999-12-13 Pharmacia & Upjohn Company 3-[(1--n-methylamino)ethyl-n-benzyl] pyrrolidine monomethanesulfonate
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
JP2003531101A (ja) 1999-06-29 2003-10-21 スミスクライン・ビーチャム・コーポレイション 細菌に対するフルオロキノロン化合物の使用法
JP2004507440A (ja) 1999-09-01 2004-03-11 スミスクライン・ビーチャム・コーポレイション 細菌に対するフルオロキノロン化合物の使用法
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
EP1242079A4 (en) 1999-09-22 2003-01-22 Smithkline Beecham Methods of anti-bacterial use of fluoroquinolonic compounds
KR20010091379A (ko) 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko) 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-ｚ-메톡시이미노피롤리딘의 신규 제조방법

Similar Documents

Publication Publication Date Title
BE2016C059I2 (ja)
BE2015C062I2 (ja)
BE2013C048I2 (ja)
BE2012C026I2 (ja)
BE2011C032I2 (ja)
BE2009C057I2 (ja)
BE2010C040I2 (ja)
JP2002057009A5 (ja)
JP2001278417A5 (ja)
BR0112866A2 (ja)
CN3135489S (ja)
CN3141399S (ja)
AU2000278679A8 (ja)
AU2000276891A8 (ja)
AU2000271150A8 (ja)
AU2000270908A8 (ja)
BY4905C1 (ja)
BY5592C1 (ja)
BY6855C1 (ja)
CL2006000179A1 (ja)
CN3133795S (ja)
CN3133951S (ja)
CN3134543S (ja)
CN3134893S (ja)
AU2000266391A8 (ja)